References
- CDC.gov [Internet]. Atlanta (GA): Centers for Disease Control and Prevention. COVID-NET: A weekly summary of U.S. COVID-19 hospitalization data. [cited 2021. Nov 12]. Available from: https://gis.cdc.gov/grasp/COVIDNet/COVID19_3.html.
- Delahoy MJ, Ujamaa D, Whitaker M, et al. COVID-NET surveillance team. Hospitalizations associated with COVID-19 among children and adolescents – COVID-NET, 14 states, March 1, 2020-August 14, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(36):1255–1260.
- Siegel DA, Reses HE, Cool AJ, et al. Trends in COVID-19 cases, emergency department visits, and hospital admissions among children and adolescents aged 0-17 years – United States, August 2020-August 2021. MMWR Morb Mortal Wkly Rep. 2021;70(36):1249–1254.
- Buonsenso D, Munblit D, De Rose C, et al. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110(7):2208–2211.
- Feldstein LR, Rose EB, Horwitz SM, et al. Overcoming COVID-19 investigators; CDC COVID-19 response team. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383(4):334–346.
- Kim L, Whitaker M, O'Halloran A, et al. COVID-NET surveillance team. Hospitalization rates and characteristics of children aged <18 years hospitalized with laboratory-confirmed COVID-19 – COVID-NET, 14 states, March 1-July 25, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1081–1088.
- Di Fusco M, Shea KM, Lin J, et al. Health outcomes and economic burden of hospitalized COVID-19 patients in the United States. J Med Econ. 2021;24(1):308–317.
- Gisaid.org/hcov19-variants [Internet]. GISAID EpiFlu™ Database, Data. Tracking of variants. [cited 6 Dec 2021. Available from: https://www.gisaid.org/hcov19-variants/.
- FDA.gov [Internet]. Silver Spring, MD: US Food & Drug Administration. FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in children 5 through 11 years of age. 2021. Oct 29; cited 2021 Nov 12]. Available from: https://www.fda.gov/news-events/press-announcements/fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use-children-5-through-11-years-age.
- ClinicalTrials.gov. [Internet]. Bethesda (MD): US National Library of Medicine. A phase 1/2/3 study to evaluate the safety, tolerability, and immunogenicity of an RNA vaccine candidate against COVID-19 in healthy children and young adults. [Last updated: 2021. Nov 11; cited 2021 Nov 15]. Available from: https://clinicaltrials.gov/ct2/show/NCT04816643.
- Businesswire. [Internet]. San Francisco (CA): Businesswire: a Berkshire Hathaway Company. Pfizer and BioNTech announce positive topline results from pivotal trial of COVID-19 vaccin in children 5 to 11 years. 2021. Sep 20; cited 2021 Nov 15]. Available from: https://www.businesswire.com/news/home/20210920005452/en/.
- Premier.com [Internet]. Charlotte (NC): Premier Applied Sciences, the Research Division of Premier Inc. Premier Healthcare Database: Data that informs and performs. 2020. Mar 2; cited 2021 Dec 9]. Available from: https://products.premierinc.com/downloads/PremierHealthcareDatabaseWhitepaper.pdf.
- Kadri SS, Gundrum J, Warner S, et al. Uptake and accuracy of the diagnosis code for COVID-19 among US hospitalizations. JAMA. 2020;324(24):2553–2554.
- Ama-assn.org [Internet]. Chicago (IL): American Medical Association. COVID-19 CPT® coding and guidance. 2021. [cited 2021 Dec 6]. Available from: https://www.ama-assn.org/find-covid-19-vaccine-codes.
- Lavery AM, Preston LE, Ko JY, et al. Characteristics of hospitalized COVID-19 patients discharged and experiencing same-hospital readmission – United State, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(45):1695–1699.
- Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Updated 2019. Oct 22 [cited 2021 Dec 6]. Available from: https://www.equator-network.org/reporting-guidelines/strobe/.
- Ohsfeldt RL, Choong CK-C, Mc Collam PL, et al. Inpatient hospital costs for COVID-19 patients in the United States. Adv Ther. 2021;38(11):5557–5595.
- NIH.gov [Internet]. Bethesda (MD): National Institutes of Health. COVID-19 treatment guidelines: special considerations in children. [Last updated 2021. Apr 21; cited 2021 Nov 15]. Available from: https://www.covid19treatmentguidelines.nih.gov/special-populations/children/.
- Edward PR, Lorenzo-Redondo R, Reyna ME, et al. Severity of illness caused by severe acute respiratory syndrome coronavirus 2 variants of concern in children: a single-center retrospective cohort study. medRxiv. 2021. Oct 26;2021.10.23.21265402. Preprint.
- Levy M, Recher M, Hubert H, et al. Multisystem inflammatory syndrome in children by COVID-19 vaccination status of adolescents in France. JAMA. 2022;327(3):281–283.
- Buonsenso D, Roland D, De Rose C, et al. Schools closures during the COVID-19 pandemic: a catastrophic global situation. Pediatr Infect Dis J. 2021;40(4):e146–e150.
- Aap.org. Itasca (IL): American Academy of Pediatrics. Children and COVID-19: state-level data report. [Last updated 2021 Dec 6; cited 2021 Dec 14]. Available from: https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/.
- [Internet]. San Francisco (CA): Kaiser Family Foundation. Kates J, Tolbert J, RouwKff.org, et al. An update on vaccine roll-out for 5-11 year-olds in the U.S. 2021. Dec 8; cited 2021 Dec 14]. Available from: https://www.kff.org/coronavirus-covid-19/issue-brief/an-update-on-vaccine-roll-out-for-5-11-year-olds-in-the-u-s/.
- Osmanov IM, Spiridonova E, Bobkova P, et al. Risk factors for long covid in previously hospitalised children using the ISARIC global follow-up protocol: a prospective cohort study. Eur Respir J. 2022;59(2):2101341.
- Buonsenso D, Di Giuda D, Sigfrid L, et al. Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-CoV-2 infection. Lancet Child Adolesc Health. 2021;5(9):677–680.